Table 2.

Total number of cervical carcinoma cases screened for FGFR3 mutation, as of august 2004.

Study	Method	Total number of cases	Mutated cases (percentage)
Cappellen et al. [5]	SSCP (entire coding region)	12	3 (25%)
Yee et al. [9]	Direct sequencing (exon 7)	104	0
Wu et al. [10]	Direct sequencing (exons 7, 10, 13, 15, and 19)	51	1 (2%)
Dai et al. [11]	Amplification created restriction site methodology for S249C mutation	91	0
Sibley et al. [12]	Direct sequencing (exons 7, 10, and 15)	28	1 (3.5%)
Present study	SSCP (exons 7, 10, and 15)	63	1 (1.5%)
Total		349	6 (1.7%)